Centre D'Oncologie de Gentilly

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy	Muscle-invasive Bladder Cancer	Active, not recruiting	Phase 3	2026-09-28		NCT04660344
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access	neoplasm	Recruiting	Not stated	2026-06-24		NCT02834884

Clinical trials